tirzepatide court ruling Judge hands win to FDA, Lilly in shortage case Court Backs FDA in Tirzepatide

Episodes of hypoglycemia in the hospital should be documented in the medical record and tracked

Ozempic (semaglutide) is a GLP-1 receptor agonist originally approved by the FDA in 2017 for the management of type 2 diabetes

BPC 157 is designed for athletes and active individuals focused on recovery, joint health, and injury prevention, particularly those undergoing intense or demanding training protocols

In vivo transomic analyses of glucose-responsive metabolism in skeletal muscle reveal core differences between the healthy and obese states

PubMed, de Luis, Daniel Antonio, Hilda F

In serious injury litigation, thorough preparation usually determines whether a claim concludes with a fair settlement or an avoidable dispute